# Audioeye Inc: overview

AEYE · Nasdaq · CIK 1362190 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aeye.md) · [Financials](/companies/aeye/financials.md) · [Filings](/companies/aeye/filings.md) · [Insiders](/companies/aeye/insiders.md)

Latest reported revenue: [$11.0m](/filings/0001104659-26-118855.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 26, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-118855).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.7 d](/filings/0001104659-26-027159.md) | [9.7](/filings/0001104659-26-059498.md) | [9.9](/filings/0001104659-26-096032.md) | [10.2](/filings/0001104659-26-118855.md) | [10.5 d](/filings/0001104659-26-027159.md) | [10.6](/filings/0001104659-26-059498.md) | [10.7](/filings/0001104659-26-096032.md) | [11.0](/filings/0001104659-26-118855.md) |
| Gross margin | % | [80.3% d](/filings/0001104659-26-027159.md) | [79.5%](/filings/0001104659-26-059498.md) | [77.3%](/filings/0001104659-26-096032.md) | [77.4%](/filings/0001104659-26-118855.md) | [78.9% d](/filings/0001104659-26-027159.md) | [78.2%](/filings/0001104659-26-059498.md) | [78.8%](/filings/0001104659-26-096032.md) | [82.9%](/filings/0001104659-26-118855.md) |
| Operating margin | % | [(13.1%) d](/filings/0001104659-26-027159.md) | [(9.7%)](/filings/0001104659-26-059498.md) | [2.5%](/filings/0001104659-26-096032.md) | [(3.1%)](/filings/0001104659-26-118855.md) | [(7.8%) d](/filings/0001104659-26-027159.md) | [(17.8%)](/filings/0001104659-26-059498.md) | [(5.6%)](/filings/0001104659-26-096032.md) | [11.4%](/filings/0001104659-26-118855.md) |
| Net margin | % | [(15.3%) d](/filings/0001104659-26-027159.md) | [(15.1%)](/filings/0001104659-26-118855.md) | [(0.0%)](/filings/0001104659-26-118855.md) | [(5.4%)](/filings/0001104659-26-118855.md) | [(10.0%) d](/filings/0001104659-26-027159.md) | [(20.0%)](/filings/0001104659-26-118855.md) | [(8.1%)](/filings/0001104659-26-118855.md) | [9.0%](/filings/0001104659-26-118855.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.00](/filings/0001104659-26-096032.md) | [(0.04)](/filings/0001104659-26-118855.md) | not reported | not reported | [(0.07)](/filings/0001104659-26-096032.md) | [0.08](/filings/0001104659-26-118855.md) |
| Free cash flow | $m | [0.5 d](/filings/0001104659-26-027159.md) | [(0.0)](/filings/0001104659-26-059498.md) | [1.2 d](/filings/0001104659-26-096032.md) | [1.0 d](/filings/0001104659-26-118855.md) | [2.5 d](/filings/0001104659-26-027159.md) | [1.2](/filings/0001104659-26-059498.md) | [1.0 d](/filings/0001104659-26-096032.md) | [1.7 d](/filings/0001104659-26-118855.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.5](/filings/0001410578-23-000236.md) | [29.9](/filings/0001410578-24-000150.md) | [31.3](/filings/0001558370-25-002819.md) | [35.2](/filings/0001104659-26-027159.md) | [40.3](/filings/0001104659-26-027159.md) |
| Gross margin | % | [75.0%](/filings/0001410578-23-000236.md) | [75.9%](/filings/0001410578-24-000150.md) | [77.7%](/filings/0001558370-25-002819.md) | [79.4%](/filings/0001104659-26-027159.md) | [78.3%](/filings/0001104659-26-027159.md) |
| Operating margin | % | [(63.3%)](/filings/0001410578-23-000236.md) | [(34.9%)](/filings/0001410578-24-000150.md) | [(19.0%)](/filings/0001558370-25-002819.md) | [(9.6%)](/filings/0001104659-26-027159.md) | [(4.5%)](/filings/0001104659-26-027159.md) |
| Net margin | % | [(58.0%)](/filings/0001410578-23-000236.md) | [(34.9%)](/filings/0001410578-24-000150.md) | [(18.8%)](/filings/0001558370-25-002819.md) | [(12.1%)](/filings/0001104659-26-027159.md) | [(7.6%)](/filings/0001104659-26-027159.md) |
| Diluted EPS | $ per share | [(1.29)](/filings/0001410578-23-000236.md) | [(0.91)](/filings/0001410578-24-000150.md) | [(0.50)](/filings/0001558370-25-002819.md) | [(0.36)](/filings/0001104659-26-027159.md) | [(0.25)](/filings/0001104659-26-027159.md) |
| Free cash flow | $m | [(5.1)](/filings/0001410578-23-000236.md) | [(5.1)](/filings/0001410578-24-000150.md) | [0.1](/filings/0001558370-25-002819.md) | [2.6](/filings/0001104659-26-027159.md) | [4.7](/filings/0001104659-26-027159.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/aeye/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-29 | [Hawkins James B](/insiders/898243.md) | Director | Purchase (P) | 3,000 | $12.3367 | $37.0k | [Form 4](/filings/0000898243-26-000025.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $4.7m | 807,893 |  | Reduced −15,561 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.0m | 351,870 |  | Added +13,325 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $1.6m | 283,469 |  | Added +191,193 |
| [Skylands Capital, LLC](/funds/1299910.md) | 2026-06-30 | $1.6m | 268,750 |  | Added +45,900 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $1.4m | 236,390 |  | Added +78,253 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.3m | 218,984 |  | Added +77,708 |
| [FORMULA GROWTH LTD](/funds/1093219.md) | 2026-06-30 | $1.2m | 200,000 |  | Unchanged |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $960.8k | 165,363 |  | Added +40,063 |
| [Focus Financial Network, Inc.](/funds/2010942.md) | 2026-06-30 | $712.6k | 122,650 |  | Added +32,270 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $691.2k | 118,973 |  | Added +31,467 |

## Recent filings

[All 696 filings](/companies/aeye/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:11 ET | [10-Q](/filings/0001104659-26-118855.md) | Quarterly report, period 2026-09-30 | 0001104659-26-118855 |
| 2026-10-26 | 16:09 ET | [8-K](/filings/0001104659-26-118780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-118780 |
| 2026-10-20 | 08:31 ET | [8-K](/filings/0001104659-26-117191.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117191 |
| 2026-09-18 | 16:10 ET | [8-K](/filings/0001104659-26-108940.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-108940 |
| 2026-08-13 | 17:11 ET | [10-Q](/filings/0001104659-26-096032.md) | Quarterly report, period 2026-06-30 | 0001104659-26-096032 |
| 2026-08-13 | 16:10 ET | [8-K](/filings/0001104659-26-095913.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095913 |
| 2026-06-23 | 08:45 ET | [8-K](/filings/0001104659-26-076658.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-076658 |
| 2026-06-18 | 08:50 ET | [8-K](/filings/0001104659-26-075458.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-075458 |
| 2026-05-26 | 16:18 ET | [8-K](/filings/0001104659-26-066285.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-066285 |
| 2026-05-13 | 16:10 ET | [DEF 14A](/filings/0001104659-26-060237.md) | Proxy statement, period 2026-06-22 | 0001104659-26-060237 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-027159.md), filed Mar 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/7aaa653c-cffa-4e08-a028-a12c27e421a5)

## About the filer

- CIK: 1362190
- Tickers: AEYE
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 18:04 ET. No prices; not investment advice.
